ESTABLISHMENT LABS HOLDINGS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.72 USD | -0.56% |
|
-2.17% | +87.76% |
| 04-03 | Citigroup Raises Price Target on Establishment Labs to $60 From $49, Maintains Buy Rating | MT |
| 04-02 | Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility | MT |
Chart calendar Establishment Labs Holdings Inc.
e.wLd3Zs1Aw3T018cOfoVVbaGM04Oi5RCExS0i5ZBHeiE.uPkTMYMRgjfMsbVYKss3WJa6mM3Ph3Hxpn5J0egMCkCLh0EsnhaqGKC4hg~3696191a3dfdd5b38748171a3907522a
Upcoming events on Establishment Labs Holdings Inc.
Past events on Establishment Labs Holdings Inc.
| 2024-03-04 10:30 | TD Cowen Health Care Conference |
| 2024-02-29 14:30 | Citi Unplugged Medtech and Life Sciences Access Day |
| 2024-02-28 16:30 | Q4 2023 Earnings Call |
| 2024-02-28 16:00 | Q4 2023 Earnings Release |
| 2024-01-10 17:15 | JPMorgan Healthcare Conference |
| 2023-11-16 11:00 | Stephens Investment Conference - Fireside Chat |
| 2023-11-14 11:30 | Jefferies London Healthcare Conference - Fireside Chat |
| 2023-11-07 16:30 | Q3 2023 Earnings Call |
| 2023-11-07 16:00 | Q3 2023 Earnings Release |
| 2023-08-08 16:30 | Q2 2023 Earnings Call |
| 2023-08-08 16:00 | Q2 2023 Earnings Release |
| 2023-06-13 13:40 | Goldman Sachs Global Healthcare Conference |
| 2023-06-07 09:00 | Jefferies Global Healthcare Conference |
| 2023-05-24 13:00 | Annual General Meeting |
| 2023-05-08 16:30 | Q1 2023 Earnings Call |
| 2023-05-08 16:00 | Q1 2023 Earnings Release |
| 2023-03-07 09:50 | Cowen Health Care Conference |
| 2023-02-27 16:30 | Q4 2022 Earnings Call |
| 2023-02-27 08:00 | Q4 2022 Earnings Release |
| 2023-01-12 10:30 | JP Morgan Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 89,6 89,3 0.3% | 84,7 83,9 0.89% | 127 126 0.37% | 162 161 0.59% | 165 165 0.09% | 180 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -24,6 -19,9 -23.38% | -21,4 -17,5 -22.43% | -35,8 -27,7 -29.35% | -60,9 -50,5 -20.61% | -12,4 |
|
EBIT Million USD | Released Forecast Spread | -30,9 -35,2 12.1% | -27,9 -22,2 -25.52% | -25,1 -22,1 -13.52% | -39,7 -36,8 -7.65% | -65,0 -63,4 -2.55% | -27,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,5 -44,0 14.81% | -38,0 -35,4 -7.29% | -39,7 -35,0 -13.46% | -72,8 -76,3 4.58% | -78,6 -78,9 0.42% | -46,5 |
|
Net income Million USD | Released Forecast Spread | -38,2 -44,6 14.46% | -38,1 -37,1 -2.86% | -41,1 -35,6 -15.53% | -75,2 -78,5 4.22% | -78,5 -81,4 3.56% | -47,7 |
|
EPS USD | Released Forecast Spread | -1,86 -2,18 14.55% | -1,63 -1,60 -1.93% | -1,72 -1,48 -16.2% | -3,08 -3,22 4.2% | -3,07 -3,17 3.24% | -1,74 |
| Announcement Date | 16/03/20 | 10/03/21 | 01/03/22 | 27/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 35,3 35,1 0.68% | 38,5 35,3 9.06% | 41,2 38,4 7.28% | 38,2 37,2 2.75% | 43,8 43,1 1.71% | 46,5 45,7 1.86% | 48,6 47,4 2.52% | 38,5 40,5 -4.88% | 31,6 31,6 0% | 35,5 | 43,9 | 48,1 | 52,9 | 53,6 |
|
EBITDA Million USD | Released Forecast Spread | -8,44 -2,44 -245.33% | -4,62 -6,50 28.89% | -9,45 -4,10 -130.49% | -9,54 -7,10 -34.35% | -12,2 -7,67 -58.75% | -7,22 -11,1 34.62% | -12,6 -12,9 2.45% | -20,0 -14,3 -39.7% | -20,9 -17,8 -17.54% | -9,02 | -2,31 | -1,17 | 0,81 | -1,10 |
|
EBIT Million USD | Released Forecast Spread | -9,37 -6,37 -47% | -5,58 -6,33 11.98% | -10,4 -6,21 -67.58% | -10,5 -10,4 -0.95% | -13,2 -10,3 -28.18% | -8,16 -12,4 34.1% | -13,7 -13,1 -4.41% | -21,0 -16,7 -25.76% | -22,1 -20,5 -8.01% | -12,9 | -6,55 | -4,91 | -2,04 | -2,30 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,4 -8,67 -54.65% | -5,53 -8,90 37.82% | -36,5 -9,38 -289.78% | -18,0 -12,8 -40.66% | -12,7 -16,4 22.14% | -11,1 -16,3 32% | -15,8 -17,6 9.94% | -28,6 -20,3 -40.91% | -23,0 -23,2 0.84% | -17,7 | -11,2 | -10,1 | -7,36 | -6,30 |
|
Net income Million USD | Released Forecast Spread | -14,2 -8,65 -64.09% | -5,93 -8,97 33.83% | -37,1 -9,58 -287.53% | -18,6 -13,2 -41.51% | -13,6 -16,9 19.67% | -11,9 -16,4 27.18% | -16,7 -18,0 6.97% | -29,3 -20,9 -39.87% | -20,5 -23,8 13.54% | -18,1 | -11,5 | -10,4 | -7,64 | -6,70 |
|
EPS USD | Released Forecast Spread | -0,59 -0,36 -64.36% | -0,24 -0,37 35.14% | -1,52 -0,39 -289.74% | -0,76 -0,54 -41.87% | -0,55 -0,68 19.51% | -0,48 -0,67 27.93% | -0,65 -0,72 9.09% | -1,12 -0,80 -39.85% | -0,79 -0,91 13.32% | -0,67 | -0,42 | -0,38 | -0,27 | -0,22 |
| Announcement Date | 01/03/22 | 09/05/22 | 08/08/22 | 07/11/22 | 27/02/23 | 08/05/23 | 08/08/23 | 07/11/23 | 28/02/24 | - | - | - | - | - |
| Today 16:05 | SILK ROAD MEDICAL, INC: Q1 2024 Earnings Release |
| Today 16:05 | MERIT MEDICAL SYSTEMS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 | REPLIGEN CORPORATION: Q1 2024 Earnings Release |
| 2024-04-30 | BAUSCH + LOMB CORPORATION: Q1 2024 Earnings Release |
| 2024-04-30 | PROCEPT BIOROBOTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:00 | LIVANOVA PLC: Q1 2024 Earnings Release |
| 2024-05-01 06:30 | CENCORA, INC.: Q2 2024 Earnings Release |
| 2024-05-01 16:01 | ATRICURE, INC.: Q1 2024 Earnings Release |
| 2024-05-01 16:10 | ENVISTA HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 | TANDEM DIABETES CARE, INC.: Q1 2024 Earnings Release |
Past sector events for Establishment Labs Holdings Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ESTA Stock
- Calendar Establishment Labs Holdings Inc.
